CD44 in Bladder Cancer

The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These sa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2024-03, Vol.16 (6), p.1195
Hauptverfasser: Duex, Jason, Theodorescu, Dan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 1195
container_title Cancers
container_volume 16
creator Duex, Jason
Theodorescu, Dan
description The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.
doi_str_mv 10.3390/cancers16061195
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10969618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788244874</galeid><sourcerecordid>A788244874</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-929290ef97c2a1fa65794ffeec90d2c3885f853976ecfa8eb6d7c551c83884ad3</originalsourceid><addsrcrecordid>eNptkctPAjEQxhujEYJc9WZIvHgB-to-TgbxmZB40XNTulNcsuxiCyb-9xZBBGLn0Enn932T6SB0QXCPMY37zlYOQiQCC0J0doSaFEvaFULz4528gdoxTnE6jBEp5ClqMJUxnVHdROfDO847RdW5LW2eQ-gMf0zP0Im3ZYT25m6ht4f71-FTd_Ty-DwcjLqOc7boapoCg9fSUUu8FZnU3HsAp3FOHVMq86tWUoDzVsFY5NJlGXEqlbjNWQvdrH3ny_EMcgfVItjSzEMxs-HL1LYw-5WqeDeT-tMQrIUWRCWH641DqD-WEBdmVkQHZWkrqJfRMEw4xlxIkdCrA3RaL0OV5jNUa0EzKrT8oya2BFNUvk6N3crUDKRSlHMleaJ6_1ApcpgVrq7AF-l9T9BfC1yoYwzgt0MSbFbrNAfrTIrL3b_Z8r_LY9_u_ZgN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2996252697</pqid></control><display><type>article</type><title>CD44 in Bladder Cancer</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Duex, Jason ; Theodorescu, Dan</creator><creatorcontrib>Duex, Jason ; Theodorescu, Dan</creatorcontrib><description>The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers16061195</identifier><identifier>PMID: 38539529</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Amino acids ; Antigens ; Bladder cancer ; Cancer ; CD44 antigen ; Cell cycle ; Cell growth ; Chemotherapy ; Development and progression ; Genomes ; Health aspects ; Hyaluronic acid ; Immune system ; Isoforms ; Ligands ; Lipids ; Metabolism ; Metastases ; Metastasis ; Proteins ; Review ; Therapeutic targets</subject><ispartof>Cancers, 2024-03, Vol.16 (6), p.1195</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 by the authors. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c443t-929290ef97c2a1fa65794ffeec90d2c3885f853976ecfa8eb6d7c551c83884ad3</cites><orcidid>0000-0002-8708-8206</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969618/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969618/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38539529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duex, Jason</creatorcontrib><creatorcontrib>Theodorescu, Dan</creatorcontrib><title>CD44 in Bladder Cancer</title><title>Cancers</title><addtitle>Cancers (Basel)</addtitle><description>The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.</description><subject>Amino acids</subject><subject>Antigens</subject><subject>Bladder cancer</subject><subject>Cancer</subject><subject>CD44 antigen</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Development and progression</subject><subject>Genomes</subject><subject>Health aspects</subject><subject>Hyaluronic acid</subject><subject>Immune system</subject><subject>Isoforms</subject><subject>Ligands</subject><subject>Lipids</subject><subject>Metabolism</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Proteins</subject><subject>Review</subject><subject>Therapeutic targets</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkctPAjEQxhujEYJc9WZIvHgB-to-TgbxmZB40XNTulNcsuxiCyb-9xZBBGLn0Enn932T6SB0QXCPMY37zlYOQiQCC0J0doSaFEvaFULz4528gdoxTnE6jBEp5ClqMJUxnVHdROfDO847RdW5LW2eQ-gMf0zP0Im3ZYT25m6ht4f71-FTd_Ty-DwcjLqOc7boapoCg9fSUUu8FZnU3HsAp3FOHVMq86tWUoDzVsFY5NJlGXEqlbjNWQvdrH3ny_EMcgfVItjSzEMxs-HL1LYw-5WqeDeT-tMQrIUWRCWH641DqD-WEBdmVkQHZWkrqJfRMEw4xlxIkdCrA3RaL0OV5jNUa0EzKrT8oya2BFNUvk6N3crUDKRSlHMleaJ6_1ApcpgVrq7AF-l9T9BfC1yoYwzgt0MSbFbrNAfrTIrL3b_Z8r_LY9_u_ZgN</recordid><startdate>20240318</startdate><enddate>20240318</enddate><creator>Duex, Jason</creator><creator>Theodorescu, Dan</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8708-8206</orcidid></search><sort><creationdate>20240318</creationdate><title>CD44 in Bladder Cancer</title><author>Duex, Jason ; Theodorescu, Dan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-929290ef97c2a1fa65794ffeec90d2c3885f853976ecfa8eb6d7c551c83884ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amino acids</topic><topic>Antigens</topic><topic>Bladder cancer</topic><topic>Cancer</topic><topic>CD44 antigen</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Development and progression</topic><topic>Genomes</topic><topic>Health aspects</topic><topic>Hyaluronic acid</topic><topic>Immune system</topic><topic>Isoforms</topic><topic>Ligands</topic><topic>Lipids</topic><topic>Metabolism</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Proteins</topic><topic>Review</topic><topic>Therapeutic targets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duex, Jason</creatorcontrib><creatorcontrib>Theodorescu, Dan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duex, Jason</au><au>Theodorescu, Dan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CD44 in Bladder Cancer</atitle><jtitle>Cancers</jtitle><addtitle>Cancers (Basel)</addtitle><date>2024-03-18</date><risdate>2024</risdate><volume>16</volume><issue>6</issue><spage>1195</spage><pages>1195-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>The glycoprotein CD44, with its many isoforms and variations in carbohydrate patterning, participates in a diverse set of cellular functions. This fact leads to the protein playing a role in many normal and pathologic cellular processes including a role in cancer progression and metastasis. These same facts make CD44 a strong therapeutic target in many cancer types, including bladder cancer.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38539529</pmid><doi>10.3390/cancers16061195</doi><orcidid>https://orcid.org/0000-0002-8708-8206</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2024-03, Vol.16 (6), p.1195
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10969618
source MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Amino acids
Antigens
Bladder cancer
Cancer
CD44 antigen
Cell cycle
Cell growth
Chemotherapy
Development and progression
Genomes
Health aspects
Hyaluronic acid
Immune system
Isoforms
Ligands
Lipids
Metabolism
Metastases
Metastasis
Proteins
Review
Therapeutic targets
title CD44 in Bladder Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T00%3A04%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CD44%20in%20Bladder%20Cancer&rft.jtitle=Cancers&rft.au=Duex,%20Jason&rft.date=2024-03-18&rft.volume=16&rft.issue=6&rft.spage=1195&rft.pages=1195-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers16061195&rft_dat=%3Cgale_pubme%3EA788244874%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2996252697&rft_id=info:pmid/38539529&rft_galeid=A788244874&rfr_iscdi=true